A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
Bambino Gesù Hospital and Research Institute
Thomas Jefferson University
University of Nebraska
Dana-Farber Cancer Institute
University of California, San Diego
Assistance Publique - Hôpitaux de Paris
Massachusetts General Hospital
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University